| Univariate analysis |  |  | Multivariate analysis |  | |
---|---|---|---|---|---|---|
 | HR | 95% CI | P value | HR | 95% CI | P value |
ALB g/L at month 6 | 0.86 | 0.76-0.96 | 0.01 | Â | Â | NS |
TA-ALB g/L | 0.8 | 0.70-0.93 | 0.002 | 0.86 | 0.75-0.98 | 0.03 |
Baseline SCr μmol/L | 1.02 | 1.01-1.04 | 0.003 |  |  | NS |
SCr μmol/L at month 3 | 1.03 | 1.02-1.05 | <0.001 |  |  | NS |
SCr μmol/L at month 6 | 1.03 | 1.02-1.04 | <0.001 |  |  | NS |
TA-SCr μmol/L | 1.02 | 1.01-1.03 | <0.001 | 1.02 | 1.01-1.03 | <0.001 |
Baseline BUN mmol/L | 1.37 | 1.14-1.65 | 0.001 | Â | Â | NS |
BUN mmol/L at month 3 | 1.35 | 1.15-1.59 | <0.001 | Â | Â | NS |
BUN mmol/L at month 6 | 1.36 | 1.10-1.69 | 0.005 | Â | Â | NS |
TA-BUN mmol/L | 1.56 | 1.25-1.94 | <0.001 | Â | Â | NS |
Baseline eGFR (ml/min/1.73 m2) | 0.97 | 0.94-0.99 | 0.01 | Â | Â | NS |
eGFR (ml/min/1.73 m2) at month 3 | 0.96 | 0.94-0.98 | 0.004 | Â | Â | NS |
eGFR (ml/min/1.73 m2) at month 6 | 0.96 | 0.93-0.98 | 0.001 | Â | Â | NS |
TA-eGFR (ml/min/1.73 m2) | 0.96 | 0.93-0.98 | 0.001 | Â | Â | NS |
UPE (g/d) at month 3 | 1 | 1.00-1.002 | 0.003 | Â | Â | NS |
TA-UPE (g/d) | 1 | 1.000-1.002 | 0.01 | Â | Â | NS |